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Edited by Shou-Wei DingAbstract Progress is being made in the development of RNA
interference-based (RNAi-based) strategies for the control of
gene expression. It has been demonstrated that small interfering
RNAs (siRNAs) can silence the expression of target genes in a
sequence-speciﬁc manner in mammalian cells. Various groups,
including our own, have developed systems for vector-mediated
speciﬁc RNAi. Vector-based siRNA- (or shRNA) expression
libraries directed against the entire human genome and siRNA
libraries based on chemically synthesized oligonucleotides now
allow the rapid identiﬁcation of functional genes and potential
drug targets. Use of such libraries will enhance our understand-
ing of numerous biological phenomena and contribute to the
rational design of drugs against heritable, infectious and
malignant diseases.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Vector-based siRNA1. Introduction
The sequence of human genome has been determined but the
functions of many genes remain unknown. Methods for bridg-
ing the gap between sequence and function are obviously nec-
essary. Various methods have been used in attempts to
suppress gene expression, exploiting, for example, antisense
oligonucleotides and ribozymes. Recently, RNA interference-
based (RNAi-based) strategies have been developed and show
considerable promise. RNAi is an evolutionarily conserved
biological phenomenon in plants and animals whereby dou-
ble-stranded RNA (dsRNA) induces the sequence-speciﬁc deg-
radation of cognate RNA [1]. This process is recognized as a
mechanism in defense of the genome against molecular para-
sites such as viruses and transposable genetic elements (trans-
posons) [2]. It is now well established that some gene
regulation is mediated by small RNAs of 19–28 nucleotides
(nt) in length, such as microRNAs (miRNAs) [3] and small*Corresponding author. Fax: +81 3 5841 7340/8828.
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doi:10.1016/j.febslet.2005.08.015interfering RNAs (siRNAs) [4], generated from precursor dsR-
NAs by ribonuclease III type enzyme Dicer. By accumulation
of many researches, RNA-mediated gene silencing has now
been developed from only biological phenomenon into very
useful experimental tool to suppress gene expression by miR-
NAs and/or more popular dsRNAs such as expressed dsRNAs
and synthetic siRNAs. This review summarizes progress to
date in optimizing RNAi and exploiting its potential.
In RNAi, a long dsRNA is processed intracellularly by
Dicer to yield siRNAs. Human Dicer has been cloned and
its ribonucleolytic activity and dsRNA-binding properties
have been characterized. Recombinant Dicer generates 21- to
23-nt products from dsRNA [5,6]. The experimental silencing
of speciﬁc genes by RNAi in mammalian systems was ham-
pered initially by the non-speciﬁc dsRNA-dependent inhibition
of protein synthesis via the protein kinase R (PKR) pathway
and the non-speciﬁc degradation of RNA that occurs upon
activation of RNase L. However, it was demonstrated that
synthetic 21- or 22-nt RNAs with 2-nt 3 0-overhangs (siRNAs)
can silence the expression of target genes without any non-
speciﬁc inhibition of gene expression in cultured mammalian
cells [7]. The synthetic siRNA duplex is similar to a naturally
processed siRNA product from long dsRNAs both in terms
of length and in terms of structure. The dominant products
of processing by Dicer are duplexes of 21- and 22-nt RNAs
with 2-nt 3 0 overhangs, which are very eﬀective mediators of
the degradation of mRNA [7,8], although slightly longer siR-
NAs of approximately 27 nts have been reported to be more
eﬀective [9,10]. It has proved possible to use siRNAs to control
the expression of both exogenous and endogenous genes in
mammalian cells [7–10].2. Design of eﬀective siRNAs
Schwarz et al. [11] showed that the two strands of an siRNA
duplex are not equally eligible for assembly into the RNA-in-
duced silencing complex (RISC) and siRNA duplexes can be
functionally asymmetric, with only one of two strands having
the ability to trigger RNAi. Therefore, it might be preferable to
design an siRNA duplex with an antisense strand that can en-
ter RISC. It has been shown statistically that siRNAs with
functional duplexes have a lower internal stability at theblished by Elsevier B.V. All rights reserved.
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Reynolds et al. [13] identiﬁed some characteristics for the ra-
tional design of siRNAs for RNAi, such as a bias towards
low internal stability at the 3 0 terminus of the sense strand.
Ui-Tei et al. reported results that were basically consistent with
these ﬁndings and the following rules appear to apply to the
induction of eﬀective gene silencing in mammalian cells: (i)
there should be A or U at the 5 0 end of the antisense strand;
(ii) there should be at least ﬁve A or U residues in the 5 0-termi-
nal one-third of the antisense strand and (iii) there should be
no GC stretch of more than 9 nt in length [14]. We also showed
that U at the 10th position in the sense strand (the middle
nucleotide of the target) tends to be associated with strong
activity [15]. Strategies for the design of eﬀective siRNAs are
becoming clearer [11–18].
Although an siRNA duplex with a bulge in its sense strand
retained most of its RNAi activity, bulges in the antisense













Fig. 1. Schematic representation of gene silencing by an shRNA-expression v
the RNA-induced silencing complex (RISC), where it targets mRNA for degpletely abolished the ability of the duplex to induce RNAi.
These observations suggested that siRNAs should be designed
to be perfectly complementary to their targets [19], although
our recent data suggest that some predetermined bulges within
expressed short hairpin RNAs (shRNAs; Fig. 1) in the sense or
antisense strand do not disturb RNAi [20]. Miller et al. [21]
demonstrated the allele-speciﬁc silencing of dominant genes
associated with two unrelated diseases and concluded that
siRNA can be engineered to silence the expression of dis-
ease-related alleles that diﬀer from wild-type alleles by as little
as a single nucleotide. However, it has been demonstrated that
siRNAs can also cross-react with targets with limited sequence
similarity [22]. Sledz et al. [23] reported that, in addition to the
speciﬁc gene-silencing eﬀects of RNAi, global interferon-stim-
ulated enhancement of gene expression can be detected in
response to the intracellular stimulation by siRNAs. Kim
et al. reported that short single-stranded RNAs (ssRNAs)












ector. The shRNA is processed by Dicer. The processed siRNA enters
radation.
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of the transcripts prevented activation of the interferon
response. Thus, their ﬁndings suggested that the interferon
response could be circumvented if the 5 0 triphosphate was
removed from the transcribed RNA [24]. It has been reported
that the interferon response can be induced by both a substan-
tial number of shRNA vectors [25] and synthetic siRNAs with
certain sequences [26,27]. Thus, use of the lowest eﬀective dose
of an shRNA vector or siRNA was recommended in order to
limit the risk of the interferon response [25].
We demonstrated recently that the introduction of G:U mis-
matches within transcribed shRNAs signiﬁcantly reduced the
extent of induction of the interferon response [28,29], without
any reduction in the extent of RNAi [30].3. Systems for the expression of shRNA and genome-wide RNAi
libraries
Because transfected synthetic siRNAs in cells can be de-
graded within a short time, inhibition of target genes does
not continue for very long. To overcome this problem, vari-
ous groups, including our own, have developed systems for
vector-mediated speciﬁc RNAi in mammalian cells [31–39]
(Fig. 1). Each of these systems exploits a polymerase III
(pol III) promoter, such as a U6 or H1 promoter or the pro-
moter of the gene for a tRNA. The various systems can be
divided into two groups depending on whether the expressed
RNA is of the tandem type or the hairpin type (Fig. 1). In
the expression system for the tandem type, both of the sense
and the antisense strand are driven separately by their own
respective promoters. In the expression system for the hairpin
type, a sequence that contains the sense strand of the siRNA
of interest, followed by a loop sequence and the antisense
strand, is driven by a single promoter. The H1 and U6 pro-
moters have been used to drive the expression of shRNAs be-
cause they produce small RNA transcripts that lack a
polyadenosine tail and have a well-deﬁned site for initiation
of transcription and a termination signal that consists of
more than four T residues in a row (>T4), which results in
3 0 overhanging U residues. Since it dose not contain any
additional nucleotides at the 3 0 end, the shRNA that is tran-
scribed from such a vector system can function eﬀectively.
The structure of the transcribed and processed shRNA clo-
sely resembles that of synthetic double-stranded siRNA
[40]. This shRNA system has been used to inhibit gene
expression in mammalian cells very eﬀectively and to an ex-
tent equal to that achieved with synthetic siRNA [41].
The genome-wide and comprehensive analysis of gene expres-
sion in various organisms should be facilitated by exploitation of
the above-described phenomenon. For example, systematic
functional analysis byRNAi of a number of genes inCaenorhab-
ditis elegans [42–47] andDrosophila cells [48–52] has allowed the
identiﬁcation of the functions of many genes. In the near future,
a similar approach using a genome-wideRNAi library should be
feasible in mammalian cells because libraries of siRNA oligonu-
cleotide and siRNA-expression vectors are becoming available.
Randomized ribozyme libraries have already been used for the
identiﬁcation of novel genes [53–68] and several groups have
begun to generate siRNA libraries directed against the entire
human genome [69–79].4. Approaches to the construction of RNAi libraries
The successes achieved by the exploitation of RNAi for the
analysis of the functions of individual genes and by use of ribo-
zyme libraries have led inevitably to eﬀorts to apply these ap-
proaches on a large scale to reverse genetic analysis. In the case
of construction of an RNAi library, the library can consist of
either synthetic siRNAs or siRNA-expression vectors. Plas-
mids and viral vectors are exploitable expression systems for
the siRNA-expression library. Each library has the advantages
and disadvantages in its delivery strategies. For example,
although viral vectors can be imported eﬃciently into various
cell lines by infection, siRNAs and plasmid vectors cannot be
imported eﬃciently into some cell lines, such as primary, neu-
ral and hemopoietic cells, by transfection. Transfection of siR-
NAs and plasmid vectors can be performed easily in ordinary
laboratories, but handlings of viral vectors require more expe-
riences and special equipments. It is necessary to choose the
delivery strategy that is optimal under a ﬁxed experimental
condition.
Genome-wide libraries of siRNAs can be constructed in sev-
eral fundamentally diﬀerent ways, which include chemical syn-
thesis and the enzymatic digestion of long dsRNAs. Because
the eﬀectiveness of siRNAs is strongly dependent on their tar-
get sites in their target RNAs, several groups developed their
own algorithm that allows one to predict favorable target sites
for generation of a high-quality library [11–18,80–90]. Some of
these algorithms are open to the public on the web. In our case,
in order to optimize various parameters, we decided to pro-
duce a large number of siRNA pairs and measure sequence–
activity relationships by walking along an entire gene and
shifting one base at a time [41]. Unfortunately, in the year
2001, the price of one siRNA pair in Japan was close to
$1000! However, Suzukis group has since developed a tran-
scription system that can be used to produce siRNAs at a rea-
sonable price [91] (Fig. 2). The advantage of their strategy is
that only completely base-paired siRNAs are collected from
the gel and, thus, the concentration of oligonucleotides reﬂects
that of duplexed siRNAs. Examination of the sequences of
approximately 1000 siRNA pairs directed against the mRNA
for EGFP and their activities enabled us to develop an original
and reliable algorithm [16,92,93].
Prior to the construction of the siRNA-expression library,
we also optimized our siRNA-expression system. We con-
structed three types of siRNA vector system, namely, a tandem
type, a dual-promoter type, and a hairpin type, and compared
the activities of the resultant siRNAs. We determined that the
hairpin-type system had the highest suppressive activity at the
low concentrations of plasmids. However, we observed a high
rate of mutation in the stem-loop region when we used plas-
mids to transform Escherichia coli. These mutations presented
a serious problem with respect to the construction of a reliable
library of siRNA vectors. However, we found that introduc-
tion of multiple C to T (or A to G) mutations into the sense
strand rendered the plasmids genetically stable and did not af-
fect silencing activity (Fig. 3). Moreover, we optimized the
loop sequence that connected the sense and antisense se-
quences and other parameters that might be expected to aﬀect
the activity of the siRNA. Together, the optimization of the
siRNA-expression system and the development of our algo-
rithm enabled us to construct a large-scale and high-quality







Fig. 2. Schematic representation of a transcription system for production of siRNA.
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siRNA-expression library that will encompass the complete ar-
ray of transcripts from the human genome (Fig. 3). To conﬁrm
that the same phenotypic changes occur when siRNAs are tar-
geted to multiple independent sites in an mRNA, our library
contains at least two target sites per gene [79].
Although our libraries are based on the optimized algorithm
for selection of the best two target sites, it might also be pos-
sible and more economical to use enzymatically fragmented
cDNAs for the construction of libraries. Indeed, several
groups have reported methods for generating libraries of ran-
dom shRNAs using fragments of enzymatically digested
cDNA [94–96]. Sen et al. described an enzyme-mediated method
for generating numerous functional siRNA constructs from
any gene of interest or any pool of genes. The restriction en-
zyme-generated siRNA (REGS) system produced, on average,
34 unique siRNAs per kilobase of sequence. REGS enabled
Sen et al. to create a complex siRNA library from double-
stranded cDNA that encompassed known and unknown genes,
with 96% of the clones containing inserts of the appropriate
size [94].
Shirane et al. produced RNAi libraries from cDNAs using
another system that they called EPRIL (enzymatic production
of RNAi library). EPRIL involves several enzymatic treat-
ments for the production of a library of shRNA-expression
vectors from cDNAs of interest and should contribute signiﬁ-
cantly to the elucidation of the gene function at the whole-
genome level [95].
Luo et al. described a system for ‘‘siRNA production by
enzymatic engineering of DNA (SPEED)’’. Theirs is a simple,
eﬀective, and inexpensive strategy for construction of genome-
wide siRNA-expression libraries from populations of double-stranded cDNAs. The method dispenses with the need for
expensive chemical synthesis of oligonucleotides and facilitates
the generation of siRNA libraries that encompass all expressed
genes, including those of unknown structure and function,
from diverse sources of mRNA in many species. In addition
to cDNA libraries, other DNAs can be converted into an siR-
NA library by SPEED, for example, the HIV genome. Screen-
ing of such a library for siRNAs that strongly inhibit viral
replication or other virus-encoded functions should help to
identify potential siRNA-based therapeutic agents [96].
One potential drawback associated with this kind of cloning
of enzymatically fragmented short DNAs is the possible pro-
duction of fragments of palindromic DNA (which lead to for-
mation of completely matched hairpin RNAs) that tend to
mutate during ampliﬁcation in E. coli, as described above.
The maintenance of reliable libraries requires special care.
Thus, we shall have to wait to assess the utility of such libraries
for the successful identiﬁcation of functional genes.5. Application of RNAi libraries
We have used our library to screen for genes involved in the
endoplasmic reticulum stress-dependent apoptosis that is in-
duced by thapsigargin, a plant-derived sesquiterpene lactone
[77]. Thapsigargin triggers endoplasmic reticulum stress, with
subsequent apoptosis, but the molecular mechanisms underly-
ing this process are incompletely understood. Using the li-
brary, we were able to identify some unexpected and novel
pathways in thapsigargin-induced apoptosis, and our results
provide evidence for the eﬃcacy and utility of the comprehen-
sive analysis of signaling networks and pathways with a library
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Fig. 3. (A) Schematic representation of the proposed siRNA-expres-
sion system. Three or four C to U or A to G mutations are introduced
into the sense strand. (B) Schematic representation of the discovery of
a novel gene using an siRNA library.
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of our siRNA-expression library, as compared with the widely
used library of synthetic siRNAs are as follows. The interferon
response in transfected cells can be avoided [28,29], and the
RNAi eﬀect is sustained for a longer period of time than are
the inhibitory eﬀects of synthetic siRNAs, in particular, in
proliferating cells. Using the siRNA-expression library, we
demonstrated the straightforward identiﬁcation of novel
pathways that had not previously been identiﬁed by other
strategies [66,67,75,77,79]. We have already constructed
siRNA libraries directed against the genes for all human
kinases and phosphatases and against the genes for all human
and mouse transcriptional factors and nuclear factors, as well
as against other human genes (15000 clones). Further analy-
ses using such large libraries of siRNA-expression vectors
should provide more precise information about various signal-ing pathways and enhance our understanding of numerous
physiological phenomena. As a consequence, they should al-
low us to identify speciﬁc disease-related target genes.
Many groups have used either libraries of synthetic siRNAs
or of siRNA-expression vectors that had been produced by the
selection of speciﬁc cleavage sites within target mRNAs [69–
74,78]. Some groups have reported the application of libraries
of synthetic siRNAs directed against certain families of genes
[70,72,78]. Aza-Blanc et al. screened HeLa cells using an siR-
NA library directed against 510 genes, including the genes
for most human kinases, to identify genes that impact
TRAIL-induced apoptosis. TRAIL is a member of the tumor
necrosis factor (TNF) superfamily that induces the selective
killing of tumor cells when bound to its cognate receptor.
Using this approach, Aza-Blanc et al. [70] identiﬁed a variety
of known and previously uncharacterized genes that modulate
TRIAL activity.
Mackeigan et al. systematically screened the kinase- and
phosphatase-encoding components of the human genome
and identiﬁed new regulators of apoptosis and chemoresis-
tance using a custom-made set of libraries of siRNAs that were
designed to include two siRNA duplexes for each gene target.
In total, their kinase library was directed against 650 target
genes and their phosphatase library was directed against 222
genes. The development of inhibitors that target these kinases
or phosphatases may lead to new anti-cancer strategies [78].
Zheng et al. reported the development of a dual-promoter
siRNA-expression system. In this system, a gene-speciﬁc
siRNA sequence is inserted between two diﬀerent opposing
pol III promoters, the mouse U6 and the human H1 promot-
ers. They used their system to construct a library of siRNA-
expression cassettes that targets 8000 human genes with two
designed sequences per gene [71]. They were able to identiﬁy
both known and unique regulators of NF-jB signaling using
this library.
Brummelkamp et al. reported the production of an
shRNA library directed against the family of de-ubiquinat-
ing enzymes [69]. Protein modiﬁcation via the conjugation
of ubiquitin moieties, known as ubiquitination, plays a ma-
jor role in many biological processes, including the cell cycle
and apoptosis. The enzymes that mediate ubiquitination
have been well studied, but much less is known about the
ubiquitin-speciﬁc proteases that mediate de-ubiquitination
of cellular substrates. To study this family of proteins, they
designed shRNA vectors for suppression of the expression of
50 human de-ubiquitinating enzymes, and used these vectors
to identify de-ubiquitinating enzymes in cancer-relevant
pathways. Using the library, they identiﬁed the tumor sup-
pressor CYLD (encoded by the familial cylindromatosis-sus-
ceptibility gene) as a suppressor of NF-jB activity. CYLD
binds to the NEMO (also known as IKKg) component of
the IkB kinase (IKK) complex and appears to regulate its
activity through de-ubiquitination of TRAF2, since the ubiq-
uitination of TRAF2 can be modulated by CYLD. Inhibi-
tion of CYLD increases resistance to apoptosis, suggesting
a mechanism through which loss of CYLD might contribute
to oncogenesis. This eﬀect can be relieved by aspirin deriva-
tives that inhibit NF-jB activity, an observation that
suggests a therapeutic intervention for restoration of growth
control in patients with familial cylindromatosis. These re-
sults led to proposals for treating cylindromatosis with exist-
ing drugs and provided powerful conﬁrmation that unbiased,
M. Ito et al. / FEBS Letters 579 (2005) 5988–5995 5993genetic approaches can lead not only to new insights in
biology but also to practical advances in the treatment of
disease.
Two independent groups have recently reported the useful-
ness of viral libraries with bar code detection [73,74]. Berns
et al. reported the construction of a set of retroviral vectors
that encode 23742 distinct shRNAs and target 7914 diﬀerent
human genes [73]. They used their library in human cells to
identify one known and ﬁve previously unknown modulators
of arrest of the p53-dependent proliferation. Suppression of
these genes conferred resistance to the arrest of both the
p53-dependent and the p19ARF-dependent proliferation of
cells, and abolished the DNA damage-induced arrest of the cell
cycle at G1 [73]. Paddison et al. reported the construction and
application of an shRNA-expression library that targeted 9610
human and 5563 mouse genes. Their library consists of close to
28000 sequence-veriﬁed shRNA-expression cassettes con-
tained within multifunctional vectors, which permit the
shRNA cassettes to be packaged in retroviruses, tracked in
mixed populations of cells by means of DNA bar codes,
and shuttled to customized vectors by bacterial mating. In or-
der to validate the library, Paddison et al. used a genetic screen
designed to identify defects in human proteasome function.
Their results suggest that large-scale RNAi libraries can be
used in speciﬁc, genetic applications in mammals and will be-
come valuable resources for gene analysis and the discovery
of potential drug targets [74,97].
Genome-wide RNAi screenings can contribute to the ra-
tional design of drugs against heritable, infectious and malig-
nant diseases. For example, Eggert et al. performed genome
wide RNAi screening combined with small molecule screening
[98]. Their parallel chemical genetic and genome wide RNAi
screens identiﬁed cytokinesis inhibitors and targets and
showed that the parallel RNA interference with small molecule
screening is useful approach to discover leads for therapeutic
drugs. In addition, Agaisse et al. performed genome-wide
RNAi screen for host factors required for intracellular bacte-
rial infection [99].
Now, a number of libraries are commercially available, for
example the MISSION shRNA library from Sigma Aldrich,
the Hannon-Elledge shRNA library from Open Bio Systems,
the smart & intelligent siRNA library from iGENE therapeu-
tics, etc. These libraries should be useful for discovery of po-
tential drug targets.6. Conclusion
The available methods for construction of RNAi libraries
each has various advantages and defects. Random libraries
are relatively inexpensive to produce and can cover an indi-
vidual gene with many diﬀerent shRNAs. However, they do
not necessarily cover all genes and the vector might not be
stable. By contrast, libraries produced from chemically syn-
thesized siRNAs are easy to handle and transfection eﬃcien-
cies are generally high, but they are expensive and the
duration of their eﬃcacy is limited. Structurally optimized
eﬀective shRNAs, transcribed from vectors in cells, can
now be generated by applying an optimized algorithm and
they can be maintained with ease. In future, siRNA libraries
will be useful for wide-range screening for drug development.There is no question that these libraries and large-scale RNAi
libraries will contribute to our understanding of numerous
biological phenomena and to the design of entire classes of
novel therapeutic agents.References
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